Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of placebos in psychiatry: a response to the draft document prepared by the Tri-Council Working Group. Canadian College of Neuropsychopharmacology.

Literature DB >> 8754591

The use of placebos in psychiatry: a response to the draft document prepared by the Tri-Council Working Group. Canadian College of Neuropsychopharmacology.

Abstract

This article is a position paper of the Canadian College of Neuropsychopharmacology (CCNP). It was approved unanimously at a meeting of the CCNP Council on June 2, 1996, and at the CCNP Annual General Business Meeting on June 4, 1996.

Keywords: Biomedical and Behavioral Research; Canadian College of Neuropsychopharmacology; Code of Conduct for Research involving Humans; Mental Health Therapies

Mesh：

Substances：
Placebos

Year: 1996 PMID： 8754591 PMCID： PMC1188779

Source DB: PubMed Journal: J Psychiatry Neurosci ISSN： 1180-4882 Impact factor: 6.186

9 in total

Review 1. Is there an alternative to the randomized controlled trial?

Authors: P Leber
Journal: Psychopharmacol Bull Date: 1991

2. Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology.

Authors: G L Klerman
Journal: Psychopharmacol Bull Date: 1986

3. Use of placebo in clinical trials.

Authors: K Rickels
Journal: Psychopharmacol Bull Date: 1986

4. A quantitative analysis of clinical drug trials for the treatment of affective disorders.

Authors: J M Davis; Z Wang; P G Janicak
Journal: Psychopharmacol Bull Date: 1993

Review 5. How sound is the double-blind design for evaluating psychotropic drugs?

Authors: S Fisher; R P Greenberg
Journal: J Nerv Ment Dis Date: 1993-06 Impact factor: 2.254

6. Concept of true and perceived placebo effects.

Authors: E Ernst; K L Resch
Journal: BMJ Date: 1995-08-26

7. Side effects and placebo amplification.

Authors: R Thomson
Journal: Br J Psychiatry Date: 1982-01 Impact factor: 9.319

8. A meta-analysis of antidepressant outcome under "blinder" conditions.

Authors: R P Greenberg; R F Bornstein; M D Greenberg; S Fisher
Journal: J Consult Clin Psychol Date: 1992-10

Review 9. Placebo as a treatment for depression.

Authors: W A Brown
Journal: Neuropsychopharmacology Date: 1994-07 Impact factor: 7.853

9 in total

5 in total

The use of placebos in psychiatry: a response to the draft document prepared by the Tri-Council Working Group. Canadian College of Neuropsychopharmacology.

Review 1. Is there an alternative to the randomized controlled trial?

2. Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology.

3. Use of placebo in clinical trials.

4. A quantitative analysis of clinical drug trials for the treatment of affective disorders.

Review 5. How sound is the double-blind design for evaluating psychotropic drugs?

6. Concept of true and perceived placebo effects.

7. Side effects and placebo amplification.

8. A meta-analysis of antidepressant outcome under "blinder" conditions.

Review 9. Placebo as a treatment for depression.

Review 1. Turn-of-the-century ethical issues in child psychiatric research.

2. The ethics of placebo in clinical psychopharmacology: the urgent need for consistent regulation.

Review 3. Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers.

4. Ethics and placebo.

5. Re: CCNP position paper on the use of placebos in psychiatry.